insights_auto
Kwa nini KROS imeongezeka kwa 2.18%?
Fahamu zaidichevron_right
KROS:NASDAQ
Keros Therapeutics Inc
US$ 10.30
arrow_upward
+2.18%(+0.22) Siku 1
13 Nov, 16:00:00 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya KROS...
Fungua
US$ 10.06
Juu
US$ 10.55
Chini
US$ 9.55
Mtaji wa soko
202.13M
Wastani wa kiasi cha mauzo
elfu 186.70
Kiasi cha mauzo ya hisa
elfu 167.04
Juu kwa wiki 52
US$ 22.55
Chini kwa wiki 52
US$ 8.98
EPS
-US$ 2.83
Beta
1.13
Hisa za wawekezaji
19.62M
Idadi ya wafanyakazi
87
Fungua
US$ 10.06
Juu
US$ 10.55
Chini
US$ 9.55
Mtaji wa soko
202.13M
Wastani wa kiasi cha mauzo
elfu 186.70
Kiasi cha mauzo ya hisa
elfu 167.04
Juu kwa wiki 52
US$ 22.55
Chini kwa wiki 52
US$ 8.98
EPS
-US$ 2.83
Beta
1.13
Hisa za wawekezaji
19.62M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
BigGo Finance
·
saa 4 zilizopita
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
saa 3 zilizopita
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
saa 1 iliyopita
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
Traders Union
·
saa 1 iliyopita
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Kuhusu Keros Therapeutics Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
Lilianzishwa2015
Makao makuuLexington, Massachusetts, Marekani
SektaHealth Care
Sekta-
Tovutikerostx.com